New rules on the temporary use authorisation (Autorisation Temporaire d’Utilisation, ATU) in France explained!
In 1994, the temporary use authorisation program was first implemented in France to allow early access to medicines for patients with serious or rare diseases when no authorised therapeutic treatment was available. Initially the ATU established to ensure patient access to human immunodeficiency viruses (HIV) therapies, and today it has expanded to cover all major […]
